Retractable Technologies, Inc. Files Motions in Connection with Becton, Dickinson and Co. Judgment
Business Wire 15-Sep-2017 5:50 PM
LITTLE ELM, Texas--(BUSINESS WIRE)-- Retractable Technologies, Inc. (NYSE American: RVP), (RTI) reports that on September 13, 2017, it filed a Motion to Alter or Amend the Judgment issued by the United States District Court for the Eastern District of Texas on August 17, 2017 which had ordered that RTI take nothing in its suit against Becton, Dickinson and Co. (BD). Such Motion asked the Court to require BD to notify end users of the facts relating to syringes, as required by the original injunction in this case.
RTI additionally reports that on September 14, 2017, it filed a Notice of Appeal to the United States Court of Appeals for the Fifth Circuit relating to the August 17 judgment discussed above.
Retractable manufactures and markets VanishPoint and Patient Safe safety medical products and the EasyPoint needle. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.
For more information on Retractable, visit its website at www.retractable.com.
Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.
Factors that could cause or contribute to such differences include, but are not limited to: Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; the impact of current and future Court decisions regarding current litigation; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to quickly increase capacity in response to an increase in demand; Retractable's ability to access the market; Retractable's ability to maintain or lower production costs; Retractable's ability to continue to finance research and development as well as operations and expansion of production; the impact of larger market players, specifically BD, in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170915005936/en/
Retractable Technologies, Inc. Douglas W. Cowan, 888-806-2626 or 972-294-1010Vice President and Chief Financial Officer
Source: Retractable Technologies, Inc.